UroCure
Minneapolis, US · Founded 2017 · Delaware LLC
Founders & leadership
Reported raises · per SEC filings
Form D private placements$2.1M disclosed across 2 rounds · 2017–2018
▶$925KraisedJan 2019 · 17 investors · Other Health CareRule 506(b)
▶$925KraisedJan 2019 · 17 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Dave StaskinDirector
- Doug KohrsDirector
- Pedram IlbeigiDirector
- John NealonExecutive Officer, Director
- Offering amount
- $1.1M
- Amount sold
- $925K
- Minimum investment
- $20K
- First sale
- Dec 2018
- Incorporated
- Limited Liability Company, Delaware, 2017
- Federal exemptions
- 06b
▶$1.2MraisedMar 2018 · 13 investors · Other Health CareRule 506(b)
▶$1.2MraisedMar 2018 · 13 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Doug KohrsExecutive Officer
- Dave StaskinExecutive Officer
- John NealonExecutive Officer, Director
- Offering amount
- $3.5M
- Amount sold
- $1.2M
- Minimum investment
- $25K
- First sale
- Jul 2017
- Incorporated
- Limited Liability Company, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- How much funding has UroCure raised?
- UroCure has disclosed $2.1M raised across 2 rounds.
- Where is UroCure headquartered?
- UroCure is headquartered in Minneapolis, US.